# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001628280-23-028848
Filing Date
2023-08-10
Accepted
2023-08-10 16:09:35
Documents
16
Period of Report
2023-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | advm-20230810.htm iXBRL | 8-K | 25942
2 | EX-99.1 | exhibit991_81023pressrelea.htm | EX-99.1 | 32118
6 | GRAPHIC | isqtdq223.jpg | GRAPHIC | 85060
7 | GRAPHIC | logo.jpg | GRAPHIC | 9327
8 | GRAPHIC | q2bsa.jpg | GRAPHIC | 1073084
| Complete submission text file | 0001628280-23-028848.txt |  | 1799347

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | advm-20230810.xsd | EX-101.SCH | 1901
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | advm-20230810_lab.xml | EX-101.LAB | 23834
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | advm-20230810_pre.xml | EX-101.PRE | 12508
10 | EXTRACTED XBRL INSTANCE DOCUMENT | advm-20230810_htm.xml | XML | 2695

Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

EIN.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36579 | Film No.: 231159402
SIC: 2836 Biological Products, (No Diagnostic Substances)